Dec 3, 2025 8:30am EST Artelo Biosciences Announces Publication of New Peer-Reviewed Study Demonstrating Intraperitoneal Administration of a Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor Significantly Reduces Stress-Induced Anxiety and Depression Behaviors in Preclinical Models
Nov 12, 2025 8:00am EST Artelo Biosciences Provides Business Update and Reports Third Quarter 2025 Financial Results
